Ironwood Pharma ( (IRWD) ) has released a notification of late filing.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ironwood Pharmaceuticals, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the identification of material weaknesses in the company’s internal controls, which have rendered its financial reporting ineffective. As a result, additional time is needed to complete management’s assessment and finalize the report. The company expects to file the Form 10-K within fifteen calendar days following the original due date. Despite the delay, Ironwood Pharmaceuticals does not anticipate any significant changes in its financial results from the previous year. The company remains committed to resolving the internal control issues and ensuring compliance with regulatory requirements, as indicated by the signature of Gregory Martini, Senior Vice President and Chief Financial Officer.
More about Ironwood Pharma
YTD Price Performance: -62.82%
Average Trading Volume: 3,185,256
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $257.6M
See more insights into IRWD stock on TipRanks’ Stock Analysis page.